Repository logo
 
Publication

From marine origin to therapeutics: the antitumor potential of marine algae-derived compounds

2018Journal article Open access
Simple item page
dc.contributor.authorAlves, Celso
dc.contributor.authorSilva, Joana
dc.contributor.authorPinteus, Susete
dc.contributor.authorGaspar, Helena
dc.contributor.authorAlpoim, Maria C.
dc.contributor.authorBotana, Luís M.
dc.contributor.authorPedrosa, Rui
dc.date.accessioned2020-06-30T15:23:18Z
dc.date.available2020-06-30T15:23:18Z
dc.date.issued2018
dc.descriptionAuthors would like to acknowledge the financial support of the Portuguese Foundation for Science and Technology (FCT) through Strategic Projects UID/MAR/04292/2013 and UID/Multi/04046/2013 granted to MARE – Marine and Environmental Sciences Centre and BioISI - BioSystems and Integrative Sciences Institute, respectively, through Red2Discovery Project (PTDC/MAR-BIO/6149/2014), cofinanced by COMPETE (POCI-01-0145-FEDER-016791), and through Oncologia de Precisão: Terapias e Tecnologias Inovadoras project (POINT4PAC) (SAICTPAC/0019/2015 - LISBOA-01-0145-FEDER-016405). The authors also wish to acknowledge the Integrated Programme of SR&TD Smart Valorization of Endogenous Marine Biological Resources Under a Changing Climate (reference Centro-01-0145-FEDER000018), co-funded by Centro 2020 program, Portugal 2020, European Union, through the European Regional Development Fund. CA, SP, and JS are financial supported by a grant from FCT (SFRH/BD/97764/2013, SFRH/BD/96203/2013, and (SFRH/BD/103255/2014, respectively).
dc.description.abstractMarine environment has demonstrated to be an interesting source of compounds with uncommon and unique chemical features on which themolecularmodeling and chemical synthesis of new drugs can be based with greater efficacy and specificity for the therapeutics. Cancer is a growing public health threat, and despite the advances in biomedical research and technology, there is an urgent need for the development of new anticancer drugs. In this field, it is estimated that more than 60% of commercially available anticancer drugs are natural biomimetic inspired. Among the marine organisms, algae have revealed to be one of the major sources of new compounds of marine origin, including those exhibiting antitumor and cytotoxic potential. These compounds demonstrated ability to mediate specific inhibitory activities on a number of key cellular processes, including apoptosis pathways, angiogenesis, migration and invasion, in both in vitro and in vivo models, revealing their potential to be used as anticancer drugs. This review will focus on the bioactive molecules from algae with antitumor potential, from their origin to their potential uses, with special emphasis to the alga Sphaerococcus coronopifolius as a producer of cytotoxic compounds.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationAlves C, Silva J, Pinteus S, Gaspar H, Alpoim MC, Botana LM and Pedrosa R (2018) From Marine Origin to Therapeutics: The Antitumor Potential of Marine Algae-Derived Compounds. Front. Pharmacol. 9:777. doi: 10.3389/fphar.2018.00777pt_PT
dc.identifier.doi10.3389/fphar.2018.00777pt_PT
dc.identifier.issn1663-9812
dc.identifier.urihttp://hdl.handle.net/10400.8/4972
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.relationNeuroprotective effects of molecules isolated from Bifurcaria bifurcata and Codium tomentosum in an in vitro and in vivo Parkinson Disease model.
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/pt_PT
dc.subjectCancerpt_PT
dc.subjectMarine natural productspt_PT
dc.subjectSeaweedspt_PT
dc.subjectIntracellular signaling pathwayspt_PT
dc.subjectBiodiversity,pt_PT
dc.subjectMarine chemical ecologypt_PT
dc.subjectSphaerococcus coronopifoliuspt_PT
dc.titleFrom marine origin to therapeutics: the antitumor potential of marine algae-derived compoundspt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.awardTitleNeuroprotective effects of molecules isolated from Bifurcaria bifurcata and Codium tomentosum in an in vitro and in vivo Parkinson Disease model.
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/5876/UID%2FMAR%2F04292%2F2013/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/5876/UID%2FMulti%2F04046%2F2013/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/9471 - RIDTI/PTDC%2FMAR-BIO%2F6149%2F2014/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/SFRH/SFRH%2FBD%2F97764%2F2013/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/SFRH/SFRH%2FBD%2F96203%2F2013/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/POR_CENTRO/SFRH%2FBD%2F103255%2F2014/PT
oaire.citation.titleFrontiers in Pharmacologypt_PT
oaire.citation.volume9pt_PT
oaire.fundingStream5876
oaire.fundingStream5876
oaire.fundingStream9471 - RIDTI
oaire.fundingStreamSFRH
oaire.fundingStreamSFRH
oaire.fundingStreamPOR_CENTRO
person.familyNameAlves
person.familyNameSilva
person.familyNamePinteus
person.familyNameGuerreiro Galla Gaspar
person.familyNamePedrosa
person.givenNameCelso
person.givenNameJoana
person.givenNameSusete
person.givenNameHelena Margarida
person.givenNameRui
person.identifier159091
person.identifier98885
person.identifier159292
person.identifierE-6798-2012
person.identifier349272
person.identifier.ciencia-id501C-F268-2E60
person.identifier.ciencia-id6317-6F15-BA35
person.identifier.ciencia-id661E-9677-74C5
person.identifier.ciencia-id761C-044C-995B
person.identifier.ciencia-id3817-33DE-919E
person.identifier.orcid0000-0003-1581-2127
person.identifier.orcid0000-0003-1224-1699
person.identifier.orcid0000-0002-3290-3111
person.identifier.orcid0000-0002-1613-7023
person.identifier.orcid0000-0003-0970-0575
person.identifier.ridB-3366-2017
person.identifier.ridB-4815-2015
person.identifier.scopus-author-id55654969100
person.identifier.scopus-author-id56370819800
person.identifier.scopus-author-id55655328300
person.identifier.scopus-author-id7003891380
person.identifier.scopus-author-id7005010300
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT
relation.isAuthorOfPublicationba5ab7c2-7474-4ea9-9bf0-ca15fe42809a
relation.isAuthorOfPublication23e68f76-0f7a-4f39-9da8-f1a26e2e2cd7
relation.isAuthorOfPublicationdb45e9a7-9e25-4fbf-903e-9feac4a23d61
relation.isAuthorOfPublication580efc75-e17e-4380-ae50-e5bc1d0bc10d
relation.isAuthorOfPublication94496a40-57cf-472f-94e1-5db9d5da78b6
relation.isAuthorOfPublication.latestForDiscovery580efc75-e17e-4380-ae50-e5bc1d0bc10d
relation.isProjectOfPublicatione2af8a5e-9119-4f07-b7d1-f70cc17b6c6d
relation.isProjectOfPublication1cefc808-0656-4268-a031-0a04acd1e1ae
relation.isProjectOfPublication382ac964-7560-45d3-b2e6-13954922bdff
relation.isProjectOfPublicationafb78be5-401e-419d-85f5-15b25e8737fd
relation.isProjectOfPublication4c67bedb-3d9d-4d2b-95c4-7cb9c02ebc96
relation.isProjectOfPublication4e599bd2-3733-4520-8d96-9035a23f9e78
relation.isProjectOfPublication.latestForDiscoverye2af8a5e-9119-4f07-b7d1-f70cc17b6c6d

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Alves et al 2018_Frontiers in Pharmacology.pdf
Size:
4.38 MB
Format:
Adobe Portable Document Format
Description:
Download

Collections

MARE - Artigos com peer review
ESTM - Artigos em revistas internacionais